Michael E. Weinblatt regularly links together related areas like Calcium in his Internal medicine studies. His study ties his expertise on Internal medicine together with the subject of Calcium. In his articles, Michael E. Weinblatt combines various disciplines, including Rheumatoid arthritis and Rituximab. Rituximab and Rheumatoid arthritis are two areas of study in which he engages in interdisciplinary work. His research on Pathology often connects related areas such as Randomized controlled trial. As part of his studies on Randomized controlled trial, Michael E. Weinblatt often connects relevant areas like Pathology. Michael E. Weinblatt integrates many fields in his works, including Placebo and Alternative medicine. Michael E. Weinblatt integrates Alternative medicine and Adverse effect in his research. He combines Adverse effect and Placebo in his research.
His Renal function research covers fields of interest such as Renal blood flow and Creatinine. He performs integrative Creatinine and Renal function research in his work. Rheumatoid arthritis and Certolizumab pegol are frequently intertwined in his study. In his works, he performs multidisciplinary study on Certolizumab pegol and Adalimumab. He performs multidisciplinary study in the fields of Adalimumab and Golimumab via his papers. Michael E. Weinblatt merges Golimumab with Methotrexate in his research. He performs multidisciplinary study in the fields of Methotrexate and Rituximab via his papers. His multidisciplinary approach integrates Rituximab and Rheumatoid arthritis in his work. In his works, he conducts interdisciplinary research on Internal medicine and Family medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Principal components analysis corrects for stratification in genome-wide association studies
Alkes L Price;Alkes L Price;Nick J Patterson;Robert M Plenge;Robert M Plenge;Michael E Weinblatt.
Nature Genetics (2006)
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
David T. Felson;David T. Felson;Jennifer J. Anderson;Jennifer J. Anderson;Maarten Boers;Claire Bombardier;Claire Bombardier.
Arthritis & Rheumatism (1995)
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
Michael E. Weinblatt;Joel M. Kremer;Arthur D. Bankhurst;Ken J. Bulpitt.
The New England Journal of Medicine (1999)
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Michael E. Weinblatt;Edward C. Keystone;Daniel E. Furst;Larry W. Moreland.
Arthritis & Rheumatism (2003)
Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial
Larry W. Moreland;Michael H. Schiff;Scott W. Baumgartner;Elizabeth A. Tindall.
Annals of Internal Medicine (1999)
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Shixin Qin;James B. Rottman;Paul Myers;Nasim Kassam.
Journal of Clinical Investigation (1998)
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
Eli A Stahl;Soumya Raychaudhuri;Soumya Raychaudhuri;Elaine F Remmers;Gang Xie.
Nature Genetics (2010)
Efficacy of low-dose methotrexate in rheumatoid arthritis.
Michael E. Weinblatt;Jonathan S. Coblyn;David A. Fox;Patricia A. Fraser.
The New England Journal of Medicine (1985)
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Eric Boilard;Peter A. Nigrovic;Peter A. Nigrovic;Katherine Larabee;Gerald F. M. Watts.
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Stanley Cohen;Eric Hurd;John Cush;Michael Schiff.
Arthritis & Rheumatism (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: